Entrada Therapeutics, Inc. (TRDA)
10.59
-0.45
(-4.08%)
USD |
NASDAQ |
Dec 09, 16:00
10.57
-0.02
(-0.19%)
After-Hours: 20:00
Entrada Therapeutics Profit Margin (Quarterly): -2.73K% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Janux Therapeutics, Inc. | -243.1% |
| NovaBay Pharmaceuticals, Inc. | -255.9% |
| Palatin Technologies, Inc. | 52.87% |
| Theriva Biologics, Inc. | -- |
| Oragenics, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -26.01% |
| Return on Assets | -21.30% |
| Return on Invested Capital | -22.75% |
| Gross Profit Margin (Quarterly) | 25.65% |
| Operating Margin (Quarterly) | -2.92K% |
| Return on Net Operating Assets | -128.5% |